NCT01230008View on ClinicalTrials.gov

Radiotherapy in Primary Mediastinal Lymphoma

CompletedOBSERVATIONAL
Enrollment

198

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

June 30, 2007

Study Completion Date

December 31, 2009

Conditions
Adjuvant Radiotherapy on Complete Remission Patients
Interventions
RADIATION

no drugs

Adjuvant radiotherapy 3.5 G will be administered or not (control group) in patients with mediastinal lymphoma,treated with R-CHOP

Trial Locations (1)

06725

Oncology Research Unit, Mèxico DF

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT01230008 - Radiotherapy in Primary Mediastinal Lymphoma | Biotech Hunter | Biotech Hunter